Skip to content

AIDS Drug Assistance Program in Crisis

  • Chad Cipiti

Over 3,500 people with HIV are on waiting lists for lifesaving antiretroviral drugs. Many more lack access because of other funding cuts and program restrictions. Congress and President Barack Obama must act now to make sure all persons with HIV…

Read more

Deadly Economics Threaten Progress to Global Health Goals

  • Chad Cipiti

By Coco Jervis and Sue Perez Over the last few years, G8 and other national leaders have lamented that health care systems in poor countries are inadequate to keep pregnant women, mothers, babies, and children healthy and that universal access…

Read more

Microbicide Field Wrestles With the Implications of Success

  • Chad Cipiti

By Richard Jefferys and Scott Morgan In July of this year, the stubborn persistence and commitment of microbicide researchers, advocates, and trial participants was finally rewarded with positive results from a South African trial of the gel form of the…

Read more

What U.S. Health Care Reform Means for People With HIV

  • Chad Cipiti

Slow Implementation for Needed Changes By Sue Perez and Coco Jervis After a century of failed efforts, decades of debate, and months of partisan rancor, this past March, Congress finally passed the Patient Protection and Affordable Care Act of 2010…

Read more

Can More People Be Put on ART Without Increased Cost?

  • Chad Cipiti

By Scott Morgan With no end to the global funding retreat in sight, new strategies are required to change the way we provide treatment to the world's 33 million people infected with HIV. On June 7-10, the Clinton Health Access…

Read more

A New Start for an Old Movement

  • Chad Cipiti

The Making of the HIV Research Catalyst Forum By Lei Chou and Coco Jervis Matt Sharp discusses the quest for a cure. After a five-year hiatus, NATAF (North American AIDS Treatment Action Forum), a community conference focused on HIV treatment…

Read more

Inflammatory Debate Over When to Start

  • Chad Cipiti

By Richard Jefferys The CD4 cell count at which combination antiretroviral therapy should be started is a central, unresolved issue in the care of HIV-1-infected patients. -- When to Start Consortium, "Timing of Initiation of Antiretroviral Therapy in AIDS-free HIV-1…

Read more

Policy Corner

  • Chad Cipiti

AIDS Drug Assistance Programs Face a Dire Situation as Waiting Lists Expand for HIV Treatment In the midst of increasing state health budget cuts and service eliminations, people living with HIV/AIDS and advocates are worried about increasing AIDS drug assistance…

Read more

Scientific Thrills and Activist Chills in Cape Town

  • Chad Cipiti

“The Vancouver of Implementation Science” meets the “Fund the Fund” Demonstration at the Cape Town AIDS Conference By Mark Harrington The Difference of a Decade For anyone who had been at the Durban, South Africa, AIDS Conference in mid- 2000,…

Read more
Back To Top